This includes the screening platform used to discover lorecivivint that utilized a colon cancer cell line with high Wnt activity and a TCF/LEF-reporter based assay to discover compounds targeting the Wnt signaling pathway [31]. This evidence concerns the gene HNF4A and colonic neoplasm.